A possible explanation for this phenomenon is that EGFR-mutated NSCLCs are associated with an uninflamed phenotype and weak immunogenicity, exhibiting lower PD-L1 expression/CD8+ TILs in the tumor microenvironment [101,102]. This evidence concerns the gene EGFR and neoplasm.